Good Luck! –
AUGUST 9, 2019 – Together, the couple is using his expertise in creating highly targeted vaccines with her expertise and experience treating and researching adolescent, teen, and young adult drug abusers and addicts.
The Levys are developing the vaccine that’s intended primarily for use in that age demographic — adolescents, teens, and young adult. The couple is also working closely with their Boston Children’s colleague, David Dowling, PhD., in collaboration with the University of Houston and Innimune, a Montana-based company focused on immunotherapeutics.
